Ps. Watson et al., Lack of effect of coenzyme Q on left ventricular function in patients withcongestive heart failure, J AM COL C, 33(6), 1999, pp. 1549-1552
Citations number
22
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES
This study evaluated the effects of oral therapy with coenzyme Q on echocar
diographic and hemodynamic indexes of left ventricular function and on qual
ity of life in patients with chronic left ventricular dysfunction.
BACKGROUND
Coenzyme Q a coenzyme for oxidative phosphorylation and an antioxidant and
free radical scavenger. It has been claimed to improve symptoms, quality of
life, left ventricular ejection fraction and prognosis in patients with ca
rdiac failure.
METHODS
Thirty patients with ischemic or idiopathic dilated cardiomyopathy and chro
nic left ventricular dysfunction (ejection fraction 26 +/- 6%) were randomi
zed to a double-blind crossover trial of oral coenzyme Q versus placebo eac
h for 3 months. Right heart pressures, cardiac output and echocardiographic
left ventricular volumes were measured at baseline and after each treatmen
t phase, and quality of life was assessed using the Minnesota "Living With
Heart Failure" questionnaire. It was calculated that to demonstrate an incr
ease in left ventricular ejection fraction from 25% to 30% with a standard
deviation of 5% using 95% confidence intervals with a power of 80% we would
require 17 patients.
RESULTS
Twenty-seven completed both treatment phases. There was no significant diff
erence in left ventricular ejection fraction, cardiac volumes or hemodynami
c and quality of life indices after treatment with coenzyme Q placebo, alth
ough plasma coenzyme Q levels increased from 903 +/- 345 nmol/l(-1) to 2,02
9 +/- 856 nmol/l(-1).
CONCLUSIONS
Inpatients with left ventricular dysfunction, treatment for three months wi
th oral coenzyme Q failed to improve resting left ventricular systolic func
tion or quality of life despite an increase in plasma levels of coenzyme Q
to more than twice basal values. (C) 1999 by the American College of Cardio
logy.